The IPO market remained active this past week as seven IPOs raised $2.1 billion. SPAC activity kept steady with 10 blank check IPOs raising $1.6 billion. New filers continued to pour into the IPO pipeline, with 12 IPOs and nine SPACs submitting initial filings. ...read more
MiNK Therapeutics, a Phase 1 biotech developing allogeneic NK T cells for cancer and other diseases, raised $40 million by offering 3.3 million shares at $12, the low end of the range of $12 to $14. The company offered 0.7 million fewer shares than anticipated. ...read more
MiNK Therapeutics, a Phase 1 biotech developing allogeneic NK T cells for cancer and other diseases, announced terms for its IPO on Tuesday. The New York, NY-based company plans to raise $52 million by offering 4 million shares at a price range of $12 to $14....read more
The IPO market was full steam ahead this past week as 11 IPOs came to market. SPAC activity remained steady with seven blank check IPOs. New filers continue to pour into the IPO pipeline, with 15 IPOs and eight SPACs submitting initial filings. Tech consultancy...read more
US IPO Weekly Recap: DevOps platform GitLab leads a 7 IPO week
The IPO market remained active this past week as seven IPOs raised $2.1 billion. SPAC activity kept steady with 10 blank check IPOs raising $1.6 billion. New filers continued to pour into the IPO pipeline, with 12 IPOs and nine SPACs submitting initial filings. ...read more
Allogeneic T cell biotech MiNK Therapeutics prices downsized IPO at $12 low end
MiNK Therapeutics, a Phase 1 biotech developing allogeneic NK T cells for cancer and other diseases, raised $40 million by offering 3.3 million shares at $12, the low end of the range of $12 to $14. The company offered 0.7 million fewer shares than anticipated. ...read more
Allogeneic T cell biotech MiNK Therapeutics sets terms for $52 million IPO
MiNK Therapeutics, a Phase 1 biotech developing allogeneic NK T cells for cancer and other diseases, announced terms for its IPO on Tuesday. The New York, NY-based company plans to raise $52 million by offering 4 million shares at a price range of $12 to $14....read more
US IPO Weekly Recap: The Fall IPO market is in full swing with an 11 IPO week
The IPO market was full steam ahead this past week as 11 IPOs came to market. SPAC activity remained steady with seven blank check IPOs. New filers continue to pour into the IPO pipeline, with 15 IPOs and eight SPACs submitting initial filings. Tech consultancy...read more